p53 protein transduction therapy: Successful targeting and inhibition of the growth of the bladder cancer cells

European Urology

Volumn 49, Issue 1, 2006, Pages 161-168

  Inoue, Miyabi ^a   Tomizawa, Kazuhito ^a   Matsushita, Masayuki ^a   Lu, Yun Fei ^a   Yokoyama, Teruhiko ^a   Yanai, Hiroyuki ^a   Takashima, Atsushi ^a   Kumon, Hiromi ^a   Matsui, Hideki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adenovirus; Bladder epithelium; Gene therapy; Protein deliverly; TAT

Indexed keywords

4 [3 (4 IODOPHENYL) 2 (4 NITROPHENYL) 2H 5 TETRAZOLIO] 1,3 BENZENE DISULFONATE; ADENOVIRUS VECTOR; CISPLATIN; POLYARGININE; PROTEIN P53; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLADDER CANCER; BLADDER TUMOR; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL TRANSPLANTATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; FEMALE; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; STAINING; VIRAL GENE THERAPY;

GENE THERAPY; HUMANS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 29044436777     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.08.019     Document Type: Article

References (17)

1. S. Al-Sukhun, and M. Hussain Current understanding of the biology of advanced bladder cancer Cancer 8 2003 2064 2075
2. I.M. Verma, and N. Somia Gene therapy-promised, problems and prospects Nature 389 1997 239 242
3. P.E. Werthman, K.E. Drazan, J.T. Rosenthal, R. Khalili, and A. Shaked Adenoviral-p53 gene transfer to orthotopic and peritoneal murine bladder cancer J Urol 155 1996 753 756
4. J.D. Chester, W. Kennedy, G.D. Hall, P.J. Selby, and M.A. Knowles Adenovirus-mediated gene therapy for bladder cancer: efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivo Gene Ther 10 2003 172 179
5. D.R. Siemens, S. Crist, J.C. Austin, J. Tartaglia, and T.L. Ratliff Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model J Urol 170 2003 979 984
6. Y. Li, R.C. Pong, J.M. Bergelson, M.C. Hall, A.I. Sagalowsky, and C.P. Tseng Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on theefficacy of gene therapy Cancer Res 59 1999 325 330
7. M.D. Sachs, K.A. Rauen, M. Ramamurthy, J.L. Dodson, A.M. De Marzo, and M.J. Putzi Integrin alpha (v) and coxsackie adenovirus receptor expression in clinical bladder cancer Urology 60 2002 531 536
8. T. Watanabe, N. Shinohara, A. Sazawa, T. Harabayashi, Y. Ogiso, and T. Koyanagi An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies Cancer Gene Ther 7 2000 1575 1580
9. S.R. Schwarze, K.A. Hruska, and S.F. Dowdy Protein transduction: unrestricted delivery into all cells? Trends in Cell Biol 10 2000 290 295
10. H. Matsui, K. Tomizawa, and Y.F. Lu Protein Therapy: in vivo protein transduction by polyarginine (11R) PTD and subcellular targeting delivery Curr Protein Pept Sci 4 2003 151 157
11. T. Takenobu, K. Tomizawa, M. Matsushita, S.T. Li, A. Moriwaki, and Y.F. Lu Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells Mol Cancer Ther 1 2002 1043 1049
12. K. Tomizawa, N. Iga, Y.F. Lu, A. Moriwaki, M. Matsushita, and S.T. Li Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade Nat Neurosci 6 2003 384 390
13. K. Nozaki, K. Tomizawa, T. Yokoyama, H. Kumon, and H. Matsui Calcineurin mediates bladder smooth muscle hypertrophy after bladder outlet obstruction J Urol 170 2003 2077 2081
14. M.J. Cooper, J.J. Haluschak, D. Johnson, S. Schwartz, L.J. Morrison, and M. Lippa p53 Mutations in bladder carcinoma cell lines Oncol Res 6 1994 569 579
15. Y. Mizutani, M. Nakao, O. Ogawa, O. Yoshida, B. Bonavida, and T. Miki Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin J Urol 165 2001 263 270
16. H.W. Herr, D.D. Wartinger, W.R. Fair, and H.F. Oettgen Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10 year followup J Urol 147 1992 1020 1023
17. C. Pfister, J.M. Flaman, F. Dunet, and P. Grise Frebourg T. p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapy J Urol 162 1999 69 73